Research output per year
Research output per year
Personal profile
Biography
Dr Casan is a dual-qualified clinical haematologist and haematopathologist, based at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital. Josh sees patients in the Aggressive Lymphoma Service at Peter Mac and is also a visiting consultant at Monash Health.
Josh's basic research is focused on developing RNA-targeting therapeutics for blood cancer; and he also has an interest in clinical research of novel therapies in haematological malignancies. Josh is a current PhD candidate in the Trapani Cancer Immunology and Johnstone Gene Regulation Laboratories.
Dr Casan was awarded an Emerging Researcher Fellowship by Monash Health and appointed to Monash University as an adjunct lecturer in 2018. Additionally, he has received the NHMRC Dora Lush postgraduate scholarship, the RACP NHMRC JJ Billings Scholarship, the Alison Street Prize in Haematology Research, the Alfred Hospital Advanced Trainee Research Prize and the Rosie Lew Postgraduate award from the Peter MacCallum Foundation.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine/Surgery, M.B.B.S (Hons)
Award Date: 10 Dec 2010
Medical Science, B.MedSci (Hons)
Award Date: 10 Dec 2010
FRACP
FRCPA
Research area keywords
- Haematology
- Lymphoma
- Genomics
- Clinical Trials
- Malignant Haematology
- Acute Leukaemia
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry
Lymphoma and Related Diseases Registry Investigators, 10 Oct 2022, In: BMC Medical Research Methodology. 22, 1, 10 p., 266.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
Fareh, M., Zhao, W., Hu, W., Casan, J. M. L., Kumar, A., Symons, J., Zerbato, J. M., Fong, D., Voskoboinik, I., Ekert, P. G., Rudraraju, R., Purcell, D. F. J., Lewin, S. R. & Trapani, J. A., 13 Jul 2021, In: Nature Communications. 12, 1, 16 p., 4270.Research output: Contribution to journal › Article › Research › peer-review
Open Access26 Citations (Scopus) -
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma
Ratnasingam, S., Casan, J., Shortt, J., Hawkes, E., Gilbertson, M., McQuilten, Z., Grigoriadis, G., Htun, K. T., Htet, S. M., Campbell, P., Chai, K. L., Quach, H., Patil, S. & Opat, S., 19 Sept 2019, In: Scientific Reports. 9, 1, 7 p., 13544.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile6 Citations (Scopus) -
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care
Casan, J. ML., Barraclough, A., Shortt, J. & Hawkes, E. A., 1 Mar 2019, In: The Lancet Haematology. 6, 3, p. e119 1 p.Research output: Contribution to journal › Letter › Other › peer-review
2 Citations (Scopus) -
Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis
Soekojo, C. Y., Wang, G., Chen, Y., Casan, J., Wolyncewicz, G., Lin, A., Poon, L. M., de Mel, S., Koh, L. P., Tan, L. K., Ooi, M. G., Nagarajan, C., Liu, Y., Lai, Y., Huang, X-J., Spencer, A., Gopalakrishnan, S. K., Lu, J. & Chng, W. J., Aug 2019, In: Clinical Lymphoma, Myeloma & Leukemia. 19, 8, p. e470-e477 8 p.Research output: Contribution to journal › Article › Research › peer-review
7 Citations (Scopus)